Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001179110-16-018119
Filing Date
2016-01-28
Accepted
2016-01-28 19:09:06
Documents
2
Period of Report
2016-01-26

Document Format Files

Seq Description Document Type Size
1 FORM 3 - edgar.html 3  
1 FORM 3 - edgar.xml 3 13530
2 POWER OF ATTORNEY ex-24omara.txt EX-24.TXT 3505
  Complete submission text file 0001179110-16-018119.txt   18604
Mailing Address 7999 GATEWAY BLVD SUITE 130 NEWARK CA 94560
Business Address 7999 GATEWAY BLVD SUITE 130 NEWARK CA 94560 510-293-8800
CymaBay Therapeutics, Inc. (Issuer) CIK: 0001042074 (see all company filings)

EIN.: 943103561 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O CYMABAY THERAPEUTICS, INC. 7999 GATEWAY BLVD., SUITE 130 NEWARK CA 94560
Business Address
OMara Patrick J. (Reporting) CIK: 0001665165 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36500 | Film No.: 161370580